Pangenotypic direct‐acting antiviral agents for mixed genotype hepatitis C infection: A real‐world effectiveness analysis

2021 ◽  
Author(s):  
Yuan‐Jie Ding ◽  
Chung‐Kuang Lu ◽  
Wei‐Ming Chen ◽  
Shui‐Yi Tung ◽  
Kuo‐Liang Wei ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Real World ◽  
Antiviral Agents ◽  
Hepatitis C Infection ◽  
Mixed Genotype ◽  
Direct Acting Antiviral ◽  
Effectiveness Analysis ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents

scholarly journals Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin

2014 ◽  
Vol 1 (1) ◽  
Author(s):  
Eric G. Meissner ◽  
Amy Nelson ◽  
Miriam Marti ◽  
Henry Masur ◽  
Anu Osinusi ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Virologic Response ◽  
Antiviral Agents ◽  
Virologic Response ◽  
Hepatitis C Infection ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents

Abstract Successful treatment of chronic hepatitis C virus infection can now be achieved using direct-acting antiviral agents without interferon. In this report, we present a patient who achieved a sustained virologic response after 27 days of treatment with sofosbuvir and ribavirin. It is imperative to identify factors that allow for shorter treatment times in some individuals.

Sign in / Sign up

Export Citation Format

Share Document